Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
- 1 February 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 347 (8997) , 297-299
- https://doi.org/10.1016/s0140-6736(96)90469-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation, 1991
- Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.Journal of Clinical Oncology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Doxorubicin-induced congestive heart failure in adultsCancer, 1985
- Right and left ventricular ejection fraction and left ventricular volume changes at rest and during exercise in normal subjectsEuropean Heart Journal, 1984
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973